ADHESION TO FIBRONECTIN PRIMES EOSINOPHILS VIA ALPHA(4)/BETA(1) (VLA-4)

Garry Michael Walsh, O CROMWELL, A B KAY, A J WARDLAW, are anwar

Research output: Contribution to journalArticle

79 Citations (Scopus)

Abstract

Human peripheral blood eosinophils adhered specifically to microtitre plates coated with plasma fibronectin (Fn) in a dose- and time-dependent fashion. Adhesion was optimal at 60 min at a concentration of 100 mu g/ml. Adherence to Fn was up-regulated by platelet-activating factor (PAF; optimum concentration of 10(-6) M) and was significantly inhibited by a polyclonal anti-Fn antibody (P < 0.05). The following evidence suggested that eosinophil adhesion to Fn was mediated by alpha(4) beta(1): (1) eosinophil adherence to Fn was not inhibited by an Arg-Gly-Asp-Ser (RGDS) synthetic peptide; (2) there was a dose-dependent adherence of eosinophils to microtitre plates coated with the 40,000 MW proteolytic fragment of Fn that contains the CS-1 alpha(4) beta(1) binding region, whereas adherence to the 120,000 MW chymotryptic fragment of Fn, which contains the RGD-dependent binding site, was weak and only observed at high concentrations (> 250 mu g/ml); (3) significant inhibition of eosinophil adherence to Fn was achieved by monoclonal antibodies (mAb) against the alpha chain of VLA-4 but not by a mAb against CD45 or a mouse myeloma antibody as negative controls. After adhesion to Fn, eosinophils were investigated for their capacity to release leukotriene C-4 in response to stimulation with a suboptimal concentration of calcium ionophore (2 x 10(-6) M). Significant enhancement of release was detected with Fn-coated plates but not with the control bovine serum albumin (BSA) (P < 0 .01). Furthermore, this enhancement was significantly inhibited by the alpha(4) beta(1) mAb HP2/1 (P < 0.05) but not by an anti-CD45 mAb. From these studies we conclude that (1) alpha(4) beta(1) (VLA-4) integrin is a major receptor for Fn on human eosinophils and (2) adhesion to Fn may prime eosinophils for mediator release during allergic inflammation.

Original languageEnglish
Pages (from-to)222-228
Number of pages7
JournalImmunology
Volume82
Issue number2
Publication statusPublished - Jun 1994

Keywords

  • VASCULAR ENDOTHELIAL-CELLS
  • HUMAN NEUTROPHIL ADHERENCE
  • PLASMA FIBRONECTIN
  • INTEGRIN RECEPTOR
  • IDENTIFICATION
  • FAMILY
  • ATTACHMENT
  • DISTINCT
  • BINDING
  • HETERODIMERS

Cite this

Walsh, G. M., CROMWELL, O., KAY, A. B., WARDLAW, A. J., & anwar , A. (1994). ADHESION TO FIBRONECTIN PRIMES EOSINOPHILS VIA ALPHA(4)/BETA(1) (VLA-4). Immunology, 82(2), 222-228.

ADHESION TO FIBRONECTIN PRIMES EOSINOPHILS VIA ALPHA(4)/BETA(1) (VLA-4). / Walsh, Garry Michael; CROMWELL, O ; KAY, A B ; WARDLAW, A J ; anwar , are.

In: Immunology, Vol. 82, No. 2, 06.1994, p. 222-228.

Research output: Contribution to journalArticle

Walsh, GM, CROMWELL, O, KAY, AB, WARDLAW, AJ & anwar , A 1994, 'ADHESION TO FIBRONECTIN PRIMES EOSINOPHILS VIA ALPHA(4)/BETA(1) (VLA-4)', Immunology, vol. 82, no. 2, pp. 222-228.
Walsh GM, CROMWELL O, KAY AB, WARDLAW AJ, anwar A. ADHESION TO FIBRONECTIN PRIMES EOSINOPHILS VIA ALPHA(4)/BETA(1) (VLA-4). Immunology. 1994 Jun;82(2):222-228.
Walsh, Garry Michael ; CROMWELL, O ; KAY, A B ; WARDLAW, A J ; anwar , are. / ADHESION TO FIBRONECTIN PRIMES EOSINOPHILS VIA ALPHA(4)/BETA(1) (VLA-4). In: Immunology. 1994 ; Vol. 82, No. 2. pp. 222-228.
@article{56180ab1c5ab446fb80faf0e15b5ba9c,
title = "ADHESION TO FIBRONECTIN PRIMES EOSINOPHILS VIA ALPHA(4)/BETA(1) (VLA-4)",
abstract = "Human peripheral blood eosinophils adhered specifically to microtitre plates coated with plasma fibronectin (Fn) in a dose- and time-dependent fashion. Adhesion was optimal at 60 min at a concentration of 100 mu g/ml. Adherence to Fn was up-regulated by platelet-activating factor (PAF; optimum concentration of 10(-6) M) and was significantly inhibited by a polyclonal anti-Fn antibody (P < 0.05). The following evidence suggested that eosinophil adhesion to Fn was mediated by alpha(4) beta(1): (1) eosinophil adherence to Fn was not inhibited by an Arg-Gly-Asp-Ser (RGDS) synthetic peptide; (2) there was a dose-dependent adherence of eosinophils to microtitre plates coated with the 40,000 MW proteolytic fragment of Fn that contains the CS-1 alpha(4) beta(1) binding region, whereas adherence to the 120,000 MW chymotryptic fragment of Fn, which contains the RGD-dependent binding site, was weak and only observed at high concentrations (> 250 mu g/ml); (3) significant inhibition of eosinophil adherence to Fn was achieved by monoclonal antibodies (mAb) against the alpha chain of VLA-4 but not by a mAb against CD45 or a mouse myeloma antibody as negative controls. After adhesion to Fn, eosinophils were investigated for their capacity to release leukotriene C-4 in response to stimulation with a suboptimal concentration of calcium ionophore (2 x 10(-6) M). Significant enhancement of release was detected with Fn-coated plates but not with the control bovine serum albumin (BSA) (P < 0 .01). Furthermore, this enhancement was significantly inhibited by the alpha(4) beta(1) mAb HP2/1 (P < 0.05) but not by an anti-CD45 mAb. From these studies we conclude that (1) alpha(4) beta(1) (VLA-4) integrin is a major receptor for Fn on human eosinophils and (2) adhesion to Fn may prime eosinophils for mediator release during allergic inflammation.",
keywords = "VASCULAR ENDOTHELIAL-CELLS, HUMAN NEUTROPHIL ADHERENCE, PLASMA FIBRONECTIN, INTEGRIN RECEPTOR, IDENTIFICATION, FAMILY, ATTACHMENT, DISTINCT, BINDING, HETERODIMERS",
author = "Walsh, {Garry Michael} and O CROMWELL and KAY, {A B} and WARDLAW, {A J} and are anwar",
year = "1994",
month = "6",
language = "English",
volume = "82",
pages = "222--228",
journal = "Immunology",
issn = "0019-2805",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - ADHESION TO FIBRONECTIN PRIMES EOSINOPHILS VIA ALPHA(4)/BETA(1) (VLA-4)

AU - Walsh, Garry Michael

AU - CROMWELL, O

AU - KAY, A B

AU - WARDLAW, A J

AU - anwar , are

PY - 1994/6

Y1 - 1994/6

N2 - Human peripheral blood eosinophils adhered specifically to microtitre plates coated with plasma fibronectin (Fn) in a dose- and time-dependent fashion. Adhesion was optimal at 60 min at a concentration of 100 mu g/ml. Adherence to Fn was up-regulated by platelet-activating factor (PAF; optimum concentration of 10(-6) M) and was significantly inhibited by a polyclonal anti-Fn antibody (P < 0.05). The following evidence suggested that eosinophil adhesion to Fn was mediated by alpha(4) beta(1): (1) eosinophil adherence to Fn was not inhibited by an Arg-Gly-Asp-Ser (RGDS) synthetic peptide; (2) there was a dose-dependent adherence of eosinophils to microtitre plates coated with the 40,000 MW proteolytic fragment of Fn that contains the CS-1 alpha(4) beta(1) binding region, whereas adherence to the 120,000 MW chymotryptic fragment of Fn, which contains the RGD-dependent binding site, was weak and only observed at high concentrations (> 250 mu g/ml); (3) significant inhibition of eosinophil adherence to Fn was achieved by monoclonal antibodies (mAb) against the alpha chain of VLA-4 but not by a mAb against CD45 or a mouse myeloma antibody as negative controls. After adhesion to Fn, eosinophils were investigated for their capacity to release leukotriene C-4 in response to stimulation with a suboptimal concentration of calcium ionophore (2 x 10(-6) M). Significant enhancement of release was detected with Fn-coated plates but not with the control bovine serum albumin (BSA) (P < 0 .01). Furthermore, this enhancement was significantly inhibited by the alpha(4) beta(1) mAb HP2/1 (P < 0.05) but not by an anti-CD45 mAb. From these studies we conclude that (1) alpha(4) beta(1) (VLA-4) integrin is a major receptor for Fn on human eosinophils and (2) adhesion to Fn may prime eosinophils for mediator release during allergic inflammation.

AB - Human peripheral blood eosinophils adhered specifically to microtitre plates coated with plasma fibronectin (Fn) in a dose- and time-dependent fashion. Adhesion was optimal at 60 min at a concentration of 100 mu g/ml. Adherence to Fn was up-regulated by platelet-activating factor (PAF; optimum concentration of 10(-6) M) and was significantly inhibited by a polyclonal anti-Fn antibody (P < 0.05). The following evidence suggested that eosinophil adhesion to Fn was mediated by alpha(4) beta(1): (1) eosinophil adherence to Fn was not inhibited by an Arg-Gly-Asp-Ser (RGDS) synthetic peptide; (2) there was a dose-dependent adherence of eosinophils to microtitre plates coated with the 40,000 MW proteolytic fragment of Fn that contains the CS-1 alpha(4) beta(1) binding region, whereas adherence to the 120,000 MW chymotryptic fragment of Fn, which contains the RGD-dependent binding site, was weak and only observed at high concentrations (> 250 mu g/ml); (3) significant inhibition of eosinophil adherence to Fn was achieved by monoclonal antibodies (mAb) against the alpha chain of VLA-4 but not by a mAb against CD45 or a mouse myeloma antibody as negative controls. After adhesion to Fn, eosinophils were investigated for their capacity to release leukotriene C-4 in response to stimulation with a suboptimal concentration of calcium ionophore (2 x 10(-6) M). Significant enhancement of release was detected with Fn-coated plates but not with the control bovine serum albumin (BSA) (P < 0 .01). Furthermore, this enhancement was significantly inhibited by the alpha(4) beta(1) mAb HP2/1 (P < 0.05) but not by an anti-CD45 mAb. From these studies we conclude that (1) alpha(4) beta(1) (VLA-4) integrin is a major receptor for Fn on human eosinophils and (2) adhesion to Fn may prime eosinophils for mediator release during allergic inflammation.

KW - VASCULAR ENDOTHELIAL-CELLS

KW - HUMAN NEUTROPHIL ADHERENCE

KW - PLASMA FIBRONECTIN

KW - INTEGRIN RECEPTOR

KW - IDENTIFICATION

KW - FAMILY

KW - ATTACHMENT

KW - DISTINCT

KW - BINDING

KW - HETERODIMERS

M3 - Article

VL - 82

SP - 222

EP - 228

JO - Immunology

JF - Immunology

SN - 0019-2805

IS - 2

ER -